The 12-year follow-up of survival, chronic adverse effects, and retention of arsenic in patients with acute promyelocytic leukemia
Lists
Only you see this
Abstract
To the editor:
Arsenic trioxide (ATO) and all-trans retinoic acid (ATRA) have demonstrated notable success in the treatment of acute promyelocytic leukemia (APL).[1][1][⇓][2]-[3][3] However, few studies have reported the adverse effects (AEs), long-term toxicity, and secondary carcinogenesis of
BibTeX
@inproceedings{zhu2016year,
author = {Hongming Zhu and Jiong Hu and Li Chen and Wei Zhou and Xiaoyang Li and Lining Wang and Xia Zhao and Yunxiang Zhang and Huijin Zhao and Aihua Wang and Yú Chen and Huiping Sun and Qiusheng Chen and Yù Chen and Weili Zhao and Jian‐Qing Mi and Zhixiang Shen and Zhenyi Wang and Chen Zhu and Sai‐Juan Chen and Junmin Li},
title = {{The 12-year follow-up of survival, chronic adverse effects, and retention of arsenic in patients with acute promyelocytic leukemia}},
booktitle = {Blood},
year = {2016},
doi = {10.1182/blood-2016-02-699439},
}Loading related content...